Anixa Accounts Payable from 2010 to 2024

ANIX Stock  USD 3.30  0.01  0.30%   
Anixa Biosciences Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable will likely drop to about 176.1 K in 2024. Accounts Payable is the amount Anixa Biosciences owes to suppliers or vendors for products or services received but not yet paid for. It represents Anixa Biosciences' short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
1990-01-31
Previous Quarter
215 K
Current Value
302 K
Quarterly Volatility
410.3 K
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Anixa Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Anixa Biosciences' main balance sheet or income statement drivers, such as Interest Expense of 216.9 K, Selling General Administrative of 4.2 M or Total Revenue of 229.4 K, as well as many indicators such as Price To Sales Ratio of 861, Dividend Yield of 0.0 or PTB Ratio of 4.39. Anixa financial statements analysis is a perfect complement when working with Anixa Biosciences Valuation or Volatility modules.
  
Check out the analysis of Anixa Biosciences Correlation against competitors.
For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.

Latest Anixa Biosciences' Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Anixa Biosciences over the last few years. An accounting item on the balance sheet that represents Anixa Biosciences obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Anixa Biosciences are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Anixa Biosciences' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Anixa Biosciences' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Anixa Accounts Payable Regression Statistics

Arithmetic Mean344,295
Geometric Mean299,584
Coefficient Of Variation50.17
Mean Deviation153,192
Median304,523
Standard Deviation172,731
Sample Variance29.8B
Range485.8K
R-Value(0.37)
Mean Square Error27.8B
R-Squared0.13
Significance0.18
Slope(14,186)
Total Sum of Squares417.7B

Anixa Accounts Payable History

2024176.1 K
2023185.4 K
2022206 K
2021265 K
2020136 K
2019232.4 K
2018585.8 K

About Anixa Biosciences Financial Statements

Anixa Biosciences investors use historical fundamental indicators, such as Anixa Biosciences' Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Anixa Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable185.4 K176.1 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Anixa Stock Analysis

When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.